|
Market Closed -
Nasdaq
21:00:00 24/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.3801 USD | -6.52% |
|
+28.28% | -23.67% |
| 09-11 | Cosmos Health Unit Enters 5-Year Contract Manufacturing Deal With Viofar Over Cardiovascular Medicine | MT |
| 09-03 | Cosmos Health Inc. Reaffirms Earnings Guidance for the Year 2026, 2027 and 2029 | CI |
| Market Cap | 38.25M 33.65M 31.72M 28.94M 54.12M 3.67B 54.54M 381M 147M 1.87B 144M 140M 6.08B | P/E 2026 * |
-1.81x | P/E 2027 * | 5.43x |
|---|---|---|---|---|---|
| Enterprise Value | 38.25M 33.65M 31.72M 28.94M 54.12M 3.67B 54.54M 381M 147M 1.87B 144M 140M 6.08B | EV / Sales 2026 * |
0.47x | EV / Sales 2027 * | 0.35x |
| Free-Float |
76.24% | Yield 2026 * |
-
| Yield 2027 * | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| COSM | Delayed | |
CBOE
| COSM | Real-time | |
|
Tradegate
| V67A | Real-time | |
|
Deutsche Boerse AG
| V67A | Delayed | |
|
Börse Stuttgart
| V67A | Delayed | |
|
Boerse Muenchen
| V67A | Real-time |
| 1 day | -6.52% | ||
| 1 week | +28.28% | ||
| Current month | +56.55% | ||
| 1 month | +83.98% | ||
| 3 months | +82.74% | ||
| 6 months | +12.99% | ||
| Current year | -23.67% |
| 1 week | 0.33 |  | 0.48 |
| 1 month | 0.2 | | 0.48 |
| Current year | 0.16 | | 0.59 |
| 1 year | 0.16 | | 1.32 |
| 3 years | 0.16 | | 2.05 |
| 5 years | 0.16 | | 150 |
| 10 years | 0.16 | | 312.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Grigorios Siokas
CEO | Chief Executive Officer | 60 | 25/02/2016 |
Georgios Terzis
DFI | Director of Finance/CFO | 43 | 10/11/2020 |
| Chief Operating Officer | 56 | 31/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 58 | 12/01/2014 | |
Grigorios Siokas
CHM | Chairman | 60 | 25/02/2016 |
John Hoidas
BRD | Director/Board Member | 59 | 17/11/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 30/07/26 | Buy | Chief Executive Officer | 349,825 | 0.5635% | ||
| 29/07/26 | Free | Chief Financial Officer | 328,407 | 0.5290% | ||
| 29/07/26 | Buy | Chief Executive Officer | 766,284 | 1.2344% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.52% | +28.28% | -65.13% | -79.12% | 38.25M | |
| -1.27% | -1.16% | +14.30% | +98.19% | 101B | |
| +0.61% | -1.64% | +44.02% | +150.25% | 51.55B | |
| -0.39% | +0.78% | -14.33% | +267.14% | 20.81B | |
| -0.25% | -0.87% | -11.20% | -10.55% | 7.93B | |
| -1.66% | -0.34% | -38.67% | -34.93% | 6.8B | |
| +2.84% | +5.64% | -1.01% | +15.64% | 6.52B | |
| -0.20% | -0.93% | -19.00% | -33.12% | 5.93B | |
| +0.52% | +1.35% | -2.19% | +20.55% | 4.95B | |
| +1.25% | +8.76% | +20.44% | +22.78% | 4.02B | |
| Average | -0.51% | +3.48% | -7.28% | +41.68% | 20.99B | |
| Weighted average by Cap. | -0.45% | -0.31% | +14.38% | +109.72% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 80.8M 71.07M 67M 61.13M 114M 7.76B 115M 804M 312M 3.95B 303M 297M 12.85B | 111M 97.46M 91.87M 83.82M 157M 10.64B 158M 1.1B 427M 5.41B 416M 407M 17.61B |
| Net income | - | - |
| Net Debt | - | - |
Employees
163
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/09/26 | US$0.3801 | -6.52% | 5,197,307 |
| 23/09/26 | US$0.4066 | +14.79% | 13,569,180 |
| 22/09/26 | US$0.3542 | +4.61% | 5,331,391 |
| 21/09/26 | US$0.3386 | +6.54% | 2,767,323 |
| 18/09/26 | US$0.3178 | +7.26% | 6,407,400 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- COSM Stock
Select your edition
All financial news and data tailored to specific country editions
